Global Patent Index - EP 2092913 A1

EP 2092913 A1 20090826 - Implantable stent prosthesis

Title (en)

Implantable stent prosthesis

Title (de)

Implantierbare Stent-Prothese

Title (fr)

Prothèse d'endoprothèse implantable

Publication

EP 2092913 A1 20090826 (EN)

Application

EP 09005881 A 20000606

Priority

  • EP 06024312 A 20000606
  • EP 00943431 A 20000606
  • US 34697599 A 19990702

Abstract (en)

The present invention relates to an implantable stent (10) prosthesis for delivering a biologically active material to a patient. The prosthesis comprises a stent body having a surface adapted for exposure to body tissue of the patient and a coating (30) disposed over at least a portion of the surface of the stent body. The coating comprises a biologically active material selected from the group consisting of anti-thrombogenic agents, anti-angiogenesis agents, anti-proliferative agents, growth factors, radiochemicals, and lovastatin, and a mixture of a first polymer and a second polymer, wherein the first polymer releases the biologically active material at a first rate and the second polymer releases the biologically active material at a second rate, wherein the second rate is slower than the first rate.

IPC 8 full level

A61F 2/06 (2006.01); A61F 2/84 (2006.01); A61K 9/00 (2006.01); A61L 31/00 (2006.01); A61L 31/10 (2006.01); A61L 31/16 (2006.01); A61P 35/00 (2006.01); A61F 2/00 (2006.01); A61F 2/90 (2006.01)

CPC (source: EP US)

A61K 9/0024 (2013.01 - EP US); A61L 31/10 (2013.01 - EP US); A61L 31/16 (2013.01 - EP US); A61P 35/00 (2017.12 - EP); A61F 2/91 (2013.01 - EP US); A61F 2250/0067 (2013.01 - EP US); A61L 2300/416 (2013.01 - EP US); A61L 2300/602 (2013.01 - EP US); A61L 2300/608 (2013.01 - EP US)

C-Set (source: EP US)

A61L 31/10 + C08L 67/04

Citation (applicant)

Citation (search report)

  • [DA] WO 9856312 A1 19981217 - SCIMED LIFE SYSTEMS INC [US]
  • [A] WO 9921908 A1 19990506 - ANGIOTECH PHARM INC [CA], et al
  • [A] EP 0737703 A2 19961016 - POLY MED INC [US]
  • [PA] E.M. JARR ET AL.: "Sustained release of lidocaine from an injectable implant system for treatment of post-operative pain", PROCEED. INT. SYMP. CONTROL. REL. BIOACT. MATER., vol. 26, July 1999 (1999-07-01), pages 631 - 632, XP002133945

Designated contracting state (EPC)

DE FR GB IE NL

Designated extension state (EPC)

AL BA RS

DOCDB simple family (publication)

WO 0101890 A1 20010111; AU 2005202342 A1 20050623; AU 5790500 A 20010122; AU 780089 B2 20050303; CA 2342866 A1 20010111; CA 2342866 C 20090127; DE 60032102 D1 20070111; DE 60032102 T2 20070628; DE 60042134 D1 20090610; EP 1107707 A1 20010620; EP 1107707 B1 20061129; EP 1757250 A2 20070228; EP 1757250 A3 20070328; EP 1757250 B1 20090429; EP 2092913 A1 20090826; EP 2292184 A1 20110309; EP 2292184 B1 20121031; JP 2003503153 A 20030128; US 2001032014 A1 20011018; US 6258121 B1 20010710; US 6569195 B2 20030527

DOCDB simple family (application)

US 0040105 W 20000606; AU 2005202342 A 20050530; AU 5790500 A 20000606; CA 2342866 A 20000606; DE 60032102 T 20000606; DE 60042134 T 20000606; EP 00943431 A 20000606; EP 06024312 A 20000606; EP 09005881 A 20000606; EP 10177262 A 20000606; JP 2001507394 A 20000606; US 34697599 A 19990702; US 88387001 A 20010618